TY - JOUR
T1 - Association of Gender With Outcome and Host Response in Critically Ill Sepsis Patients
AU - van Vught, Lonneke A.
AU - Scicluna, Brendon P.
AU - Wiewel, Maryse A.
AU - Hoogendijk, Arie J.
AU - Klein Klouwenberg, Peter M. C.
AU - Ong, David S. Y.
AU - Cremer, Olaf L.
AU - Horn, Janneke
AU - Franitza, Marek
AU - Toliat, Mohammad R.
AU - Nürnberg, Peter
AU - Bonten, Marc M. J.
AU - Schultz, Marcus J.
AU - van der Poll, Tom
AU - AUTHOR GROUP
AU - de Beer, Friso M.
AU - Bos, Lieuwe D. J.
AU - Frencken, Jos F.
AU - Glas, Gerie J.
AU - van Hooijdonk, Roosmarijn T. M.
AU - Huson, Michaëla A. M.
AU - Schouten, Laura R. A.
AU - Straat, Marleen
AU - Wieske, Luuk
AU - Witteveen, Esther
PY - 2017
Y1 - 2017
N2 - Objective: To determine the association of gender with the presentation, outcome, and host response in critically ill patients with sepsis. Design and Setting: A prospective observational cohort study in the ICU of two tertiary hospitals between January 2011 and January 2014. Patients: All consecutive critically ill patients admitted with sepsis, involving 1,815 admissions (1,533 patients). Interventions: The host response was evaluated on ICU admission by measuring 19 plasma biomarkers reflecting organ systems implicated in sepsis pathogenesis (1,205 admissions) and by applying genome-wide blood gene expression profiling (582 admissions). Measurements and Main Results: Sepsis patients admitted to the ICU were more frequently males (61.0%; p <0.0001 vs females). Baseline characteristics were not different between genders. Urosepsis was more common in females; endocarditis and mediastinitis in men. Disease severity was similar throughout ICU stay. Mortality was similar up to 1 year after ICU admission, and gender was not associated with 90-day mortality in multivariate analyses in a variety of subgroups. Although plasma proteome analyses (including systemic inflammatory and cytokine responses, and activation of coagulation) were largely similar between genders, females showed enhanced endothelial cell activation; this difference was virtually absent in patients more than 55 years old. More than 80% of the leukocyte blood gene expression response was similar in male and female patients. Conclusions: The host response and outcome in male and female sepsis patients requiring ICU admission are largely similar
AB - Objective: To determine the association of gender with the presentation, outcome, and host response in critically ill patients with sepsis. Design and Setting: A prospective observational cohort study in the ICU of two tertiary hospitals between January 2011 and January 2014. Patients: All consecutive critically ill patients admitted with sepsis, involving 1,815 admissions (1,533 patients). Interventions: The host response was evaluated on ICU admission by measuring 19 plasma biomarkers reflecting organ systems implicated in sepsis pathogenesis (1,205 admissions) and by applying genome-wide blood gene expression profiling (582 admissions). Measurements and Main Results: Sepsis patients admitted to the ICU were more frequently males (61.0%; p <0.0001 vs females). Baseline characteristics were not different between genders. Urosepsis was more common in females; endocarditis and mediastinitis in men. Disease severity was similar throughout ICU stay. Mortality was similar up to 1 year after ICU admission, and gender was not associated with 90-day mortality in multivariate analyses in a variety of subgroups. Although plasma proteome analyses (including systemic inflammatory and cytokine responses, and activation of coagulation) were largely similar between genders, females showed enhanced endothelial cell activation; this difference was virtually absent in patients more than 55 years old. More than 80% of the leukocyte blood gene expression response was similar in male and female patients. Conclusions: The host response and outcome in male and female sepsis patients requiring ICU admission are largely similar
U2 - https://doi.org/10.1097/CCM.0000000000002649
DO - https://doi.org/10.1097/CCM.0000000000002649
M3 - Article
C2 - 28806220
SN - 0090-3493
VL - 45
SP - 1854
EP - 1862
JO - Critical care medicine
JF - Critical care medicine
IS - 11
ER -